Vystar Corporation announced the appointment of Steven Rotman as its Chief Executive Officer and member of the Board of Directors, appointment of three new members to its Board of Directors and relocation of its headquarters to Worcester, Massachusetts, effective immediately. Mr. Rotman brings extensive management experience to Vystar. He has been President and CEO of Rotmans. In addition he is the founder and managing partner of NHS Holdings. William Doyle, Vystar's previous CEO and Chairman, will continue with Vystar as a Product Development Consultant and has relinquished his seat on the Board of Directors. In addition to Steven Rotman, Vystar has appointed Bryan Stone, M.D., and Joseph Allegra, PhD., to its Board of Directors. Dr. Stone has advised Vystar over the past years relating to product development for the healthcare industry and brings to the board an understanding of the challenges of new product development for start-up companies. He is the Chairman of Medicine at Desert Regional Medical Center in Palm Springs, Calif., and is the Medical Director at multiple DaVita Dialysis Centers. He is also an entrepreneur, serving as the Interim CEO of Fluid Energy Conversion Inc. Dr. Allegra has followed Vystar's progress for numerous years and has assisted as an investment advisor and investor, providing insight into positioning the company to attract investors, particularly in the healthcare sector. He currently is an Instructor of Epidemiology and Biostatistics at the University of Georgia and an Investment Advisor at Lincoln Lee Investments in Atlanta. Previously he was a Senior Drug Safety Associate at Genentech.

The company announced relocation of its headquarters to Worcester, Massachusetts, effective immediately.